Telmito-Beta 25 Tablets

Composition

• • Telmisartan – 40 mg
  • Metoprolol Succinate (Extended Release) – 25 mg

https://enriselifesciences.com/wp-admin/post.php?post=279&action=edit

---

Mechanism of Action

Telmisartan blocks angiotensin II type 1 (AT1) receptors, leading to vasodilation and reduced blood pressure by preventing vasoconstriction and aldosterone release.

Metoprolol Succinate (ER) is a cardioselective beta-1 blocker that reduces heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and reducing cardiac workload.

The combination offers dual benefits by controlling both vascular resistance and heart rate.

---

Key Benefits

• Dual-action control of hypertension
• Helps reduce heart rate and cardiac workload
• Provides sustained 24-hour blood pressure control
• Reduces risk of cardiovascular events
• Suitable for patients with hypertension and associated cardiac conditions

---

Indications

• Hypertension (High Blood Pressure)
• Patients with hypertension and tachycardia or cardiac risk
• Cardiovascular risk management

---

Dosage & Administration

• To be taken as directed by the physician
• Usually administered once daily
• Should be taken at the same time each day for optimal effect

---

Precautions

• Monitor blood pressure and heart rate regularly
• Use cautiously in patients with asthma or bronchospastic disorders
• Caution in patients with hepatic or renal impairment
• Do not abruptly discontinue therapy
• Avoid use during pregnancy

---

Contraindications

• Severe bradycardia or heart block
• Hypersensitivity to any component
• Severe hypotension
• Pregnancy (unless advised by a physician)

---

Storage

• Store in a cool and dry place below 25°C
• Protect from light and moisture
• Keep out of reach of children

---

Packaging

• 10 x 15 Tablets